Altogether, these findings support a direct link between microbiota diversity, and expansion of a gut-born population of IL-17+ cells that also preferentially accumulate in the BM of mice with MM, and contribute to the pathogenesis of the disease. This evidence concerns the gene IL17A and Miyoshi myopathy.